Why is Cohance Life falling/rising?

As of 06-Aug, Cohance Lifesciences Ltd's stock price is currently at Rs 937.55, reflecting a decline of Rs 23.45 or 2.44%. The stock has underperformed its sector by 0.38% today and opened with a loss of 3.01%. It is trading close to its 52-week low, just 1.71% away from Rs 921.5. Over the past week, the stock has decreased by 6.05%, and its year-to-date performance shows a significant drop of 17.28%. Despite a high management efficiency indicated by a return on equity (ROE) of 22.91% and a low debt-to-equity ratio, the company faces challenges such as a poor long-term growth outlook with a declining operating profit and a substantial fall in profit after tax over the last quarter.
In the broader market context, the Sensex has only fallen by 1.15% over the past week, indicating that the decline in Cohance Lifesciences' stock is more pronounced than the general market trend. The pharmaceutical and drugs sector has also seen a decrease of 2.17%, contributing to the stock's downward movement. Additionally, a significant drop in investor participation, with delivery volume falling by 73.14% against the five-day average, suggests waning interest in the stock. Overall, while the stock has shown strong returns over the long term, recent performance metrics and market conditions point to a troubling outlook for Cohance Lifesciences Ltd.